Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IMD-catechol is an innovative dimer compound combining an imidazoquinolinone structure with NF-κB immunomodulatory activity, which enhances treatment outcomes in a CT26 mouse colon carcinoma model and demonstrates low adjuvant-related toxicity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 486,500 |
50 mg | 約6-8 週間 | ¥ 638,000 |
100 mg | 約6-8 週間 | ¥ 849,500 |
説明 | IMD-catechol is an innovative dimer compound combining an imidazoquinolinone structure with NF-κB immunomodulatory activity, which enhances treatment outcomes in a CT26 mouse colon carcinoma model and demonstrates low adjuvant-related toxicity. |
分子量 | 538.64 |
分子式 | C31H34N6O3 |
CAS No. | 2928463-39-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IMD-catechol 2928463-39-0 NF-Κb NF-κB Inhibitor inhibitor inhibit